HAT1 and posterior cortical atrophy: Collectively, these results demonstrate that the abnormal expression of HAT1 promotes PCa and CRPC tumorigenesis by upregulating AR expression, and inhibition of HAT1 expression may shed new lights on CRPC treatment.